Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial biofilm extracellular polymeric substance (EPS) matrix and bacterial cell membranes represent a critical structural and protective barrier for microbial communities. The EPS matrix is a complex assembly of polysaccharides, proteins, and extracellular DNA (eDNA) that anchors bacteria to surfaces and shields them from host immune responses and antimicrobial penetration (Flemming & Wingender, 2010, Nature Reviews Microbiology). Beneath this matrix, the bacterial cell membrane serves as the primary metabolic and osmotic barrier, maintaining cellular integrity and regulating transport. Therapeutic strategies targeting these structures involve the use of matrix-degrading enzymes, such as Dornase alfa, to break down the physical scaffold, or membrane-active agents like daptomycin and polymyxins that induce pore formation and cell death (Hall & Mah, 2017, FEMS Microbiology Reviews). Disrupting these components is essential for treating recalcitrant chronic infections where traditional antibiotics fail due to poor penetration or the presence of persistent bacterial cells (Pozo & Patel, 2007, Clinical Pharmacology & Therapeutics). Furthermore, targeting the membrane remains a cornerstone of treating multi-drug resistant Gram-negative and Gram-positive pathogens (Humphries et al., 2013, Clinical Microbiology Reviews).
Enzymatic degradation of matrix components such as extracellular DNA or polysaccharides to increase antibiotic penetration; physical disruption of the bacterial lipid bilayer through pore formation, depolarization, and leakage of intracellular contents.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial biofilm extracellular polymeric substance matrix and bacterial cell membrane (EPS matrix and cell membrane).